Value & Access Head Greece

Salary Range: €84,420.00 - €156,780.00   Job Description Summary Access Directors are dedicated to co-developing innovative and winning market access strategies, optimizing the payer value proposition and access-relevant evidence packages for assets, in partnership with the CLS and cross-functional teams. They develop and implement transformative access solutions serving strategic disease areas (DAs) and maximizing Novartis assets, with focus on our priority geographic markets, major HTA archetypes and Budget Impact archetypes needs and feasibility. Access Directors, • Represent access with internal partners and external stakeholders. Internally, drive vision, inspire and provide leadership throughout the Access community (International, Regions, Countries) and with key partners (CPS/International, Development, Biomedical Research, Operations, S&G, Regions and Countries). Externally, represent Novartis in appropriate fora and organizations to drive the Novartis strategic access agenda. • With International TA, develop and deliver all aspects of access strategy and execution for compounds/brands across the R-D-C continuum. • Collaborate and partner with TAs, Medical Affairs, Development and Biomedical Research to enhance the value proposition, access strategy and access-relevant evidence packages. Ensure access landscaping and payer evidence requirements are built into TPPs, clinical development plans, integrated product strategies, indication sequencing/asset maximization. • Enable asset strategy to translate science into payer and HCS value propositions and solutions, securing access, affordability, and contribute to wide scale patient access and efficiencies at scale. • With CLS and Pricing team, (co-)create the international pricing strategy and guidance. • With CLS, generate payer negotiation strategy, upskill and prepare countries for their payer negotiations. • With CLS, create innovative patient access and contracting approaches, Managed Entry Agreements (MEAs) and Patient Support Programs (PSPs) as required, to improve patient outcomes and support healthcare system affordability. • Ensure the appropriate and timely access inputs into IEPs, IPS, asset maximization incl. indication sequencing. • Create collaborative partnerships internally and externally to break down silos, partner across the value chain and shape the future of healthcare and markets. • Manage resource requirements to address asset/DA priorities.   Job Description Major Accountabilities: • Developing and operationalizing the Integrated Product Access strategy • Create and champion a compelling and competitive international strategic vision for how Novartis will innovate and expand access through DAs for the benefit of patients, Healthcare Systems, Payers, and Novartis • Active leadership in internal fora - enable broad country insights and alignment, and leverage external fora (e.g., EMA/EUnetHTA & advisory boards) to pressure-test strategies, level of evidence etc. for feasibility and success. • With the TA, develop the international integrated product access strategy (IPAS) to deliver product differentiation most relevant to payers (e.g., well-defined target population, clinical endpoints, comparators, outcome measures, utility instruments, Health Economics data), patients, and HCS stakeholders worldwide. • Ensure that at launch, Novartis brands are supported by a robust payer value proposition particularly featuring core elements; ‘Value for money’ story, strong value evidence package and a pricing strategy maximizing the lifetime value of the brand (including existing and future evidence to justify price) and the reputation of Novartis. • Ensure access team develops and represents expert value evidence input into TPPs, clinical programs (including